MedPath

Moxidectin

MOXIDECTIN tablets, for oral use These highlights do not include all the information needed to use MOXIDECTIN safely and effectively. See full prescribing information for MOXIDECTIN . Initial U.S. Approval: 2018

Approved
Approval ID

6eb02ae9-9065-176f-e053-2991aa0ac891

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2023

Manufacturers
FDA

Medicines Development for Global Health

DUNS: 754191398

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Moxidectin

PRODUCT DETAILS

NDC Product Code71705-050
Application NumberNDA210867
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateNovember 30, 2023
Generic NameMoxidectin

INGREDIENTS (1)

MOXIDECTINActive
Quantity: 2 mg in 1 1
Code: NGU5H31YO9
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Moxidectin - FDA Drug Approval Details